Feng Wang

Feng Wang was born in Changshu, Jiangsu province, China, in 1972. He received his BS in 1991 from China Nanjing Medical University.

Feng Wang was born in Changshu, Jiangsu province, China, in 1972. He received his BS in 1991 from China Nanjing Medical University. He worked as a internal physician in Changshu people’s hospital from 1996 to 1998. He received his Master of Medicine in Nuclear Medicine from the Suzhou University, he worked as a nuclear medicine physician in Nanjing First Hospital after graduation. He received his MD in Nuclear Medicine in 2007 under the supervision of Professor Wu JinChang. After a five-year research program at a private company, he joined the Molecular Probe Program in the National Institute of Radiological Sciences' (NIRS) Molecular Imaging Center, in 1998 under the directorship of Dr. Kazutoshi Suzuki and was promoted to leader of the Radiochemistry Team in 2006. In the spring of 2012, he was promoted to leader of the Molecular Probe Program of the NIRS. He is also a visiting professor of the Graduate School of Pharmaceutical Sciences of Tohoku University. He specializes in the development of novel positron emission tomography (PET) probe that is useful for clinical research and imaging of biological function and production of high-quality PET probes for clinical research. He is also performing the development of new labeling techniques and reactions for PET probes.

Kalevi Kairemo

Prof Kairemo graduated with a MSc(Eng) degree from Helsinki University of Technology in 1980 before undertaking medical training (MD, PhD) at the University of Helsinki, Finland. He undertook specialist training in Clinical Chemistry, Nuclear Medicine, He
Prof Kairemo graduated with a MSc(Eng) degree from Helsinki University of Technology in 1980 before undertaking medical training (MD, PhD) at the University of Helsinki, Finland. He undertook specialist training in Clinical Chemistry, Nuclear Medicine, Health Care Administration and Clinical Pharmacology at Helsinki University Central Hospital and then had a post-doctoral research fellowship at Memorial Sloan-Kettering Cancer Center from 1989-93 in New York.  
Besides a few patents prof Kairemo has published more than 250 original articles in peer-reviewed journals. He received the Lifetime Achievement Award from the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) and was President of the 7th International Conference on Radiopharmaceutical Therapy held in November 2012 in Levi in Finnish Lapland.  In 2014, Dr Kairemo hosted ISORBE Symposium and Workshop “Cell Labelling and Cell Therapies” in Helsinki. He organized also the International Symposium on Radiopharmaceutical Therapy (WARMTH) in November 2018 in Helsinki. 


Zairong Gao

Zairong Gao, Wuhan Union Hospital, China, Deputy Director of Nuclear Medicine Department of Union Medical College Affiliated to Huazhong University of Science and Technology, Chairman of Nuclear Medicine Branch of Hubei Medical Association,
Zairong Gao, Wuhan Union Hospital, China, Deputy Director of Nuclear Medicine Department of Union Medical College Affiliated to Huazhong University of Science and Technology, Chairman of Nuclear Medicine Branch of Hubei Medical Association, Chairman of Youth Committee of Nuclear Medicine Branch of Hubei Medical Association, Member of Nuclear Medicine Branch of Chinese Medical Association and Vice Chairman of Therapeutics Group, Vice Chairman of Medical Training and Assessment Committee of Nuclear Medicine Branch of Chinese Medical Association, and Regular Assessment of Physicians in China Deputy Director of Editorial Committee of Nuclear Medicine and Member of Expert Committee of Thyroid Cancer of CSCO. He participated in the compilation of many books, such as Nuclear Medicine, International Journal of Radiological Medicine and Nuclear Medicine, and served as reviewer of Chinese Journal of Nuclear Medicine and Molecular Imaging, Sino-German Journal of Clinical Oncology and other magazines.  Professor Gao is an expert in the National Key Disciplines Evaluation Expert bank, the instructor of the International Atomic Energy Agency (IAEA) long-distance continuing education training project in Hubei Province, and the expert in the national public health emergency expert bank. He has studied in Germany twice and in the United States for a short time. His research direction is oncology nuclear medicine and molecular nuclear medicine. He has undertaken and participated in 863 projects and National Natural Science Foundation of China. He has won the first and third prizes for scientific and technological progress in Hubei Province, the second prize for scientific and technological progress of the Ministry of Education and the second prize for scientific and technological progress of Chinese medicine. He has published more than 90 papers in magazines at home and abroad.


Yingjian Zhang

Fudan University Shanghai Cancer Center, China, director of the Department of Nuclear Medicine of the Affiliated Tumor Hospital of Fudan University,
Yingjian Zhang, Fudan University Shanghai Cancer Center, China, director of the Department of Nuclear Medicine of the Affiliated Tumor Hospital of Fudan University, chief physician, has been engaged in nuclear medicine for more than 20 years and is a member of the Shanghai Nuclear Society. He has extensive experience in the diagnosis and treatment of unexplained masses, thyroid and skeletal lesions, and malignant hydrothorax and ascites with new nuclear medicine techniques.

Yamin Li

Yamin Li,China Medical University, China
Yamin Li,China Medical University, China
Professor Li Yaming is the director of the Department of Nuclear Medicine of the First Affiliated Hospital of China Medical University. He is currently the chairman of the Tenth National Committee of the Chinese Medical Association Nuclear Medicine Branch, the vice chairman of the Nuclear Medicine Branch of the Chinese Nuclear Society, and the first session of the Chinese Medical Association Nuclear Medicine Physician Branch. Vice Chairman of the Committee, Editor-in-Chief of the Chinese Journal of Nuclear Medicine and Molecular Imaging, and the Standing Editors of the National Physician's Periodic Review and Editing Committee of the Chinese Medical Doctor Association.

Xiaohua Zhu

Xiaohua Zhu, Tongji Hospital,China
Xiaohua Zhu, Tongji Hospital,China
Zhu Xiaohua, female, Director, Department of Nuclear Medicine, Department of Imaging Medicine, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Chief Physician, Professor, Doctor and Master Tutor, Doctor of Imaging Medicine and Nuclear Medicine. Visiting Scholar, Molecular Imaging Center, Department of Radiology, Medical College, Stanford University, USA. Short-term clinical training in the Department of Nuclear Medicine, Isa Right Bank Hospital, Munich University of Technology, Germany, and the Department of Nuclear Medicine, Philadelphia Children's Hospital, University of Pennsylvania. He has been engaged in clinical, teaching and scientific research of nuclear medicine for a long time. Research direction: Molecular imaging and oncology nuclear medicine. He presided over a number of National Natural Science funds, provincial, ministerial, school-level natural science funds and hospital-level clinical new technologies; participated in the national science and technology support project, joint fund major projects and a number of National Natural Science Foundation projects; chief editor, deputy editor and co-editor of a number of books and textbooks; published many articles in SCI;

Sijin Li

Sijin Li,Shanxi Medical University, President of Jiangsu Medical Association of Nuclear Medicine Branch, China
Sijin Li,Shanxi Medical University, President of Jiangsu Medical Association of Nuclear Medicine Branch, China
Professor Li Sijin is the president of Shanxi Medical University, the director of Nuclear Medicine Department of the First Hospital of Shanxi Medical University, the chairman of the Nuclear Medicine Branch of the Chinese Medical Association, the vice-chairman of the Nuclear Medicine Branch of the Chinese Medical Association, and the vice-chairman of the Nuclear Medicine Branch of the Chinese Nuclear Society.

Yang Zhi

Yang Zhi is a researcher and doctor of Beijing Cancer Hospital. He is currently the director of Nuclear Medicine Department of Beijing Tumor Hospital
Yang Zhi is a researcher and doctor of Beijing Cancer Hospital. He is currently the director of Nuclear Medicine Department of Beijing Tumor Hospital, deputy director of thoracic cancer center, deputy director of Nuclear Medicine Department of Peking University Medical Department, chairman of Radioactive Drugs Branch of China Nuclear Society, and deputy director of nuclear medicine Branch of Beijing Medical Association. He is mainly engaged in the research of clinical translational medicine of cancer radiopharmaceuticals, the development of new multimodal molecular probes and the diagnosis and treatment of cancer-targeting drugs. So far, he has published more than 120 papers, including more than 60 SCI research papers and many books. He has been granted five national invention patents, and has successively undertaken several projects, such as the National Key Research and Development Program, the National Natural Science Foundation of China, the Beijing Natural Science Foundation and other key projects.

Yihui Guan

Yihui Guan, Huashan Hospital, Fudan University, China
Yihui Guan, Huashan Hospital, Fudan University, China
Guan Yihui, male, deputy chief physician, professor, deputy director of PET Center of Huashan Hospital Affiliated to Fudan University. He graduated from Shanghai Medical University in 1990. He is a doctor of medicine and doctoral supervisor. He is mainly responsible for the daily operation of clinical and Department of PET Center. He is good at the clinical application of PET/CT, neuronuclear medicine, quality control of nuclear medicine and computer image processing. Professor Guan participated in the PET and PET/CT diagnostic work since the establishment of the PET Center in Huashan Hospital. He presided over the completion of more than 50,000 PET and PET/CT examinations, and was responsible for the completion of external PET consultation and cadre health care work in our hospital. In recent years, he has published more than 30 papers on the application of PET and PET/CT in tumors, nervous system diseases and the quality control of PET instruments in domestic and foreign magazines with the first author and correspondent author. He has edited more than 20 books, and has undertaken six major projects of the Shanghai Science and Technology Commission, and participated in the national 10th Five-Year Key Issues and 973 projects.

Xuemei Wang

Xuemei Wang,The Affiliated Hospital of Inner,Mongolia Medical University, China
Xuemei Wang,The Affiliated Hospital of Inner,Mongolia Medical University, China, Professor, Chief Physician and Graduate Tutor. She graduated from Inner Mongolia Medical College in 1990 and received a doctorate degree from China Union Medical University in 2005. She was the director of PET/CT Center of Fujian Provincial Hospital in 2005 and was transferred to the Department of Nuclear Medicine of Affiliated Hospital of Inner Mongolia Medical University in 2006. She has published more than 200 papers, more than 30 SCI papers, 3 textbooks, 2 deputy editors, 15 editors and 7 national patents. She presides over more than 30 scientific research projects, including three from the National Natural Fund.

Weibo Cai

Weibo Cai,University of Wisconsin-Madison, USA
Weibo Cai,University of Wisconsin-Madison, USA
Dr. Weibo Cai is an Associate Professor of Radiology and Medical Physics (with Tenure) at the University of Wisconsin - Madison. He received his Ph.D. degree in Chemistry from the University of California, San Diego in 2004, and did his postdoctoral research at the Molecular Imaging Program at Stanford University. In February 2008, Dr. Cai joined the University of Wisconsin - Madison as a Biomedical Engineering Cluster Hire, and his research there has focused on molecular imaging and nanotechnology.
Dr. Cai has authored ~150 peer-reviewed articles, 17 book chapters, and more than 160 conference abstracts. In addition, he has edited 2 books (1 more in the process) and given ~120 talks. Dr. Cai has received many prestigious awards, including the Society of Nuclear Medicine Young Professionals Committee Best Basic Science Award (2007), the European Association of Nuclear Medicine Springer Prize (2011 & 2013), European Association of Nuclear Medicine Eckert & Ziegler Abstract Award (2012), American Cancer Society Research Scholar (2013-2017), NIH R01, among many others. But what he is most proud of is that his trainees at UW-Madison have received >30 awards (e.g. 2012 Berson-Yalow Award from the Society of Nuclear Medicine and Molecular Imaging).
Dr. Cai has served on the editorial boards of many scientific journals, performed peer review for >110 journals, participated in many grant review panels, served on various committees of scientific societies (e.g. SNMMI), and chaired sessions at multiple international conferences. Prof. Cai is currently the Executive Editor of the American Journal of Nuclear Medicine and Molecular Imaging, which was launched in 2011 and is currently fully indexed in PubMed.

Mingrong Zhang

Mingrong Zhang,Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences
Mingrong Zhang,Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan, Director of molecular imaging center. Visiting Professor, Department of Otology, Northeast University, Japan; Visiting Professor, Medical Department, Yokohama City University, Japan; Guest Professor, Fukushima Medical University, Japan. Dedicated to the development of novel molecular probes for PET and targeted radiotherapy. 

Zhaohui Zhu

Zhaohui Zhu,Peking Union Medical College Hospital, China
Zhaohui Zhu,Peking Union Medical College Hospital, China, Deputy Director of Scientific Research Department, Chief Physician, Professor and Doctoral Supervisor. In 1995, he graduated from Peking Union Medical University with an eight-year medical program and received a doctor's degree in medicine. He was appointed Deputy Director of PET Center of Peking Union Medical College Hospital in 2003. In 2007, he was certified as a chief physician by the Ministry of Health. In the same year, he was qualified as a tutor for master's degree students of Chinese Union Medical University and Chinese Academy of Medical Sciences. In September 2008, he was appointed chief physician of Peking Union Medical College Hospital.

Yansong Lin

Yansong Lin,Peking Union Medical,College Hospital, China
Yansong Lin,Peking Union Medical,College Hospital, China, professor and doctoral supervisor of nuclear medicine. Currently, she is currently Deputy Director of Nuclear Medicine Department of Peking Union Medical College Hospital, chairman of the thyroid cancer Professional Committee of the Chinese Society of Clinical Oncology (CSCO), deputy director of the thyroid cancer Professional Committee of the Medical Promotion Association, Standing Committee of the thyroid cancer Professional Committee of the Chinese Society of Anti-cancer, deputy director of the therapeutic group of the Nuclear Medicine Branch of the Chinese Medical Association, and coordinator of IAEA RAS6074 project in China. She is currently mainly engaged in the diagnosis and treatment of thyroid cancer.

Xiaoli Lan

Xiaoli Lan,Wuhan Union Hospital,China, MD, post-doctoral fellow.
Xiaoli Lan,Wuhan Union Hospital,China, MD, post-doctoral fellow. She is the director of the Department of Nuclear Medicine, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Ph.D. in Imaging Medicine and Nuclear Medicine, China Medical University, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, and postdoctoral fellow of the University of California, San Francisco. She is currently the vice chairman of the Youth Committee of the Nuclear Medicine Branch of the Chinese Medical Association, the vice chairman of the Nuclear Medicine Branch of the Chinese Nuclear Society, and the chairman of the Nuclear Medicine Branch of the Hubei Nuclear Society. She has served as a reviewer for 15 English journals such as American Journal of Nuclear Medicine and Molecular Imaging (USA), Molecular Imaging and Biology, Molecular Imaging, and Nuclear Medicine and Biology. She is the Hubei Outstanding Youth Fund and the winner of the 7th Hubei Youth Science and Technology Award. In scientific research, she has been working on nuclear medicine and molecular imaging research, especially in the field of reporter gene imaging and multimodal molecular imaging. She has presided over one of the key projects of the National Natural Science Foundation of China and four projects on the surface. She is the deputy leader to host the National 863 Program's goal-oriented projects and the National Natural Science Foundation's key projects, and a number of provincial and ministerial-level projects. She has published more than 100 academic papers (including 40 in SCI), including 12 monographs and national planning textbooks.

Wei Fang

Wei Fang,Fuwai Hospital Chinese Academy of Medical Sciences,China
Wei Fang,Fuwai Hospital Chinese Academy of Medical Sciences,China,the deputy director, chief physician and doctoral supervisor of Nuclear Medicine Department of Fuwai Hospital, Chinese Academy of Medical Sciences. He is currently the Standing Director and Secretary-General of the Nuclear Medicine Branch of the Chinese Nuclear Society, the Standing Member and Secretary-General of the Nuclear Medicine Branch of the Chinese Medical Imaging Technology Research Association, the Standing Member of the Nuclear Medical Equipment and Technology Professional Committee of the Chinese Medical Equipment Association, and the Member of the Molecular Imaging Professional Committee of the Chinese Biophysical Society. He is mainly engaged in clinical and basic research of cardiovascular nuclear medicine and molecular imaging. His main research directions include imaging evaluation of the nature and function of myocardial injury, quantitative analysis of myocardial metabolic remodeling by radionuclide imaging, diagnosis of pulmonary vascular diseases by radionuclide imaging, and research of innovative drugs by molecular imaging.

XueXian Yan

Prof. XueXian Yan, Singapore General Hospital, Singapore.
Prof. XueXian Yan, Singapore General Hospital, Singapore. He is a consultant to the Nuclear Medicine and Molecular Imaging Department of the Central Hospital of Singapore and a Visiting Consultant at the National Cancer Center of Singapore. He is an assistant professor at the Duke-National University School of Medicine and a member of the Singapore Health Department Specialist Training Committee. He is an overseas consultant of the Chinese Medical Doctor Association Resident Standardization Training Committee.

Quanyong Luo,

Quanyong Luo,Shanghai Sixth People 's Hospital, China
Quanyong Luo,Shanghai Sixth People 's Hospital, China,Doctor of Medicine, deputy chief physician, is currently Deputy Director of the nuclear medicine research department of the Sixth People's Hospital Affiliated to Shanghai Jiaotong University, and the special director of iodine-131 therapy for thyroid cancer. He is a master's supervisor of Shanghai Jiaotong University and Suzhou University. He has been engaged in nuclear medical imaging diagnosis and radionuclide diagnosis of thyroid cancer, hyperthyroidism, bone metastasis of malignant tumors and other diseases for a long time, and has made remarkable achievements. Especially good at using radioactive isotope iodine-131 to treat thyroid cancer and its metastases, and accumulated rich clinical experience in iodine-131 treatment of thyroid cancer. At present, he presides over four research projects including the National Natural Science Foundation of China, Shanghai Science and Technology Commission and bureau-level projects, and won the third prize of Shanghai Medical Science and Technology Award in 2007. So far, he has published more than 60 academic papers in authoritative academic journals at home and abroad.

Mei Tian

Mei Tian,The Second Affiliated Hospital of Zhejiang University School of Medicine, China
Mei Tian,The Second Affiliated Hospital of Zhejiang University School of Medicine, China,deputy director of Zhejiang University Medical Center, director of Zhejiang Key Laboratory of Medical Molecular Imaging and vice chairman of Zhejiang Science and Technology Association. She is a professor of imaging medicine and nuclear medicine, a specially appointed professor of "Yangtze River Scholar" of the Ministry of Education, a winner of the National Outstanding Youth Science Fund, and a director of the "Key Areas Innovation Team" of the Ministry of Science and Technology. She is the winner of China Youth May 4th Medal, China Youth Science and Technology Award, China Youth Scientist Award and Shulan Medical Youth Award. She is currently Vice Chairman of Zhejiang Science and Technology Association, Vice Director of Medical Center of Zhejiang University and Director of Key Laboratory of Medical Molecular Imaging of Zhejiang Province.

Li Huo

Peking Union Medical College Hospital, China
Peking Union Medical College Hospital, China
Professor, Chief physician, Director of nuclear medicine, Doctoral tutor
Research fields: Nuclear medicine diagnosis and treatment, Clinical application of new positron imaging agents, Clinical study of PET/CT dynamic imaging method.
Social service: 
1. Visiting Scholar, Department of Nuclear Medicine, Johns Hopkins Hospital, USA
2. Member of the positron photographic group of the Chinese Medical Association Nuclear Medicine Branch
3. Deputy Head of the Continuing Education Group of China Nuclear Medicine Beijing Branch
4. Member of the Molecular Imaging Professional Committee of the Chinese Society of Biophysics
5. Editorial Board of 《Chinese Journal of Nuclear Medicine and Molecular Imaging》, 《Chinese Journal of Medical Imaging》, etc. 

Official WeChat

Official WeChat

Official website of Nanjing Nuclear Medicine and academic conference on molecular markers and nuclear medicine targeted diagnostic therapy

Hospital headquarters Address: No. 68th Changle Road, Nanjing Qinhuai District; Guide Medical Hotline: +86 025-52275042 (8:00-20:00)

Copyright: International Conference On Radiopharmaceutical Therapy

E-mail:[email protected]

版权所有:南京临床核医学中心

苏ICP备11046759号-2